Dennis Poon

620 total citations
27 papers, 425 citations indexed

About

Dennis Poon is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Dennis Poon has authored 27 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Dennis Poon's work include Cancer therapeutics and mechanisms (4 papers), Gastrointestinal motility and disorders (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Dennis Poon is often cited by papers focused on Cancer therapeutics and mechanisms (4 papers), Gastrointestinal motility and disorders (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Dennis Poon collaborates with scholars based in Singapore, United Kingdom and Guatemala. Dennis Poon's co-authors include Melvin L.K. Chua, Eugenia L.L. Yeo, Hok Sum Chan, Muthu Kumara Gnanasammandhan Jayakumar, Anwei Cheng, Xiang Zheng, G.L. French, Jervoise Andreyev, Akshaya Bansal and Yong Zhang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Dennis Poon

24 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dennis Poon Singapore 12 112 89 86 71 60 27 425
Jianli Hu China 13 52 0.5× 40 0.4× 27 0.3× 147 2.1× 111 1.9× 40 390
Nan He China 13 105 0.9× 71 0.8× 26 0.3× 146 2.1× 30 0.5× 33 472
Qingyun Long China 10 82 0.7× 48 0.5× 20 0.2× 44 0.6× 51 0.8× 21 457
Jaewoong Lee South Korea 13 29 0.3× 54 0.6× 113 1.3× 108 1.5× 47 0.8× 49 534
Susan Shamimi‐Noori United States 8 75 0.7× 64 0.7× 19 0.2× 148 2.1× 60 1.0× 21 419
Tiecheng Liu China 13 76 0.7× 25 0.3× 31 0.4× 186 2.6× 66 1.1× 36 609
Daniel Glass United Kingdom 15 32 0.3× 45 0.5× 141 1.6× 206 2.9× 115 1.9× 33 872
Shi Wang China 13 162 1.4× 27 0.3× 25 0.3× 135 1.9× 84 1.4× 86 724
Piaopiao Jin China 11 91 0.8× 24 0.3× 26 0.3× 58 0.8× 154 2.6× 29 377
Amy P. Wu United States 9 170 1.5× 171 1.9× 30 0.3× 99 1.4× 110 1.8× 12 597

Countries citing papers authored by Dennis Poon

Since Specialization
Citations

This map shows the geographic impact of Dennis Poon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis Poon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis Poon more than expected).

Fields of papers citing papers by Dennis Poon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dennis Poon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis Poon. The network helps show where Dennis Poon may publish in the future.

Co-authorship network of co-authors of Dennis Poon

This figure shows the co-authorship network connecting the top 25 collaborators of Dennis Poon. A scholar is included among the top collaborators of Dennis Poon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dennis Poon. Dennis Poon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yeo, Eugenia L.L., et al.. (2025). Combinatorial functionomics identifies HDAC6-dependent molecular vulnerability of radioresistant head and neck cancer. Experimental Hematology and Oncology. 14(1). 5–5.
2.
Greer, Charles R., Gauraang Bhatnagar, Caroline L. Hoad, et al.. (2025). pTRACK-generated normalized average T2 signal intensity and fistula volume are accurate and sensitive measures of perianal Crohn’s disease activity. British Journal of Radiology. 99(1178). 299–304.
3.
4.
Poon, Dennis, Graham R. Law, Giles Major, & Jervoise Andreyev. (2022). A systematic review and meta-analysis on the prevalence of non-malignant, organic gastrointestinal disorders misdiagnosed as irritable bowel syndrome. Scientific Reports. 12(1). 1949–1949. 18 indexed citations
5.
6.
Tan, Hong Qi, Eugenia L.L. Yeo, Dennis Poon, et al.. (2020). Dosimetric uncertainties impact on cell survival curve with low energy proton. Physica Medica. 76. 277–284. 1 indexed citations
7.
Poon, Dennis, Bhuvaneswari Ramaswamy, Zhongguo Liang, et al.. (2019). Vandetanib sensitizes head and neck squamous cell carcinoma to photodynamic therapy through modulation of EGFR-dependent DNA repair and the tumour microenvironment. Photodiagnosis and Photodynamic Therapy. 27. 367–374. 17 indexed citations
8.
Zhang, Zhen, Muthu Kumara Gnanasammandhan Jayakumar, Xiang Zheng, et al.. (2019). Upconversion superballs for programmable photoactivation of therapeutics. Nature Communications. 10(1). 4586–4586. 124 indexed citations
9.
Poon, Dennis, et al.. (2019). What is the cost of delayed diagnosis of bile acid malabsorption?. Clinical Medicine. 19(2). s55–s55. 2 indexed citations
10.
Poon, Dennis, et al.. (2018). What is the cost of delayed diagnosis of bile acid malabsorption and bile acid diarrhoea?. Frontline Gastroenterology. 10(1). 72–76. 18 indexed citations
11.
Mohammad, Farhan, et al.. (2016). Concordance and incongruence in preclinical anxiety models: Systematic review and meta-analyses. Neuroscience & Biobehavioral Reviews. 68. 504–529. 53 indexed citations
12.
Choo, Su Pin, Balram Chowbay, Quan Sing Ng, et al.. (2012). A Phase 1 dose-finding and pharmacodynamic study of rapamycin in combination with bevacizumab in patients with unresectable hepatocellular carcinoma. European Journal of Cancer. 49(5). 999–1008. 20 indexed citations
13.
Chow, Pierce K. H., Dennis Poon, Su Pin Choo, et al.. (2009). Phase I study of SIR-sphere plus sorafenib as first-line treatment in patients with nonresectable hepatocellular carcinoma: The Asia-Pacific Hepatocellular Carcinoma Trials Group protocol 05 (AHCC05). Journal of Clinical Oncology. 27(15_suppl). e15538–e15538. 8 indexed citations
14.
Huynh, Hung, Vy Ngo, Su Pin Choo, et al.. (2009). Sunitinib (SUTENT, SU11248) Suppresses Tumor Growth and Induces Apoptosis in Xenograft Models of Human Hepatocellular Carcinoma. Current Cancer Drug Targets. 9(6). 738–747. 26 indexed citations
15.
Poon, Dennis, et al.. (2009). An exploratory analysis of comprehensive geriatric assessment results and overall survival in 233 consecutive elderly cancer patients. Journal of Clinical Oncology. 27(15_suppl). 9504–9504. 4 indexed citations
16.
Poon, Dennis, et al.. (2006). Phase II Trial of Gemcitabine and Cisplatin Sequentially Administered in Asian Patients With Unresectable or Metastatic Non-small Cell Lung Cancer. Annals of the Academy of Medicine Singapore. 35(1). 33–37. 4 indexed citations
17.
Poon, Dennis, et al.. (2005). Concurrent Chemoradiotherapy followed by Surgery in Locally Advanced Squamous Cell Carcinoma of the Oesophagus: A Single Centre Experience. Annals of the Academy of Medicine Singapore. 34(5). 369–375. 4 indexed citations
18.
Poon, Dennis, et al.. (2004). Two Case Reports of Metastases from Colon Carcinoma to the Thyroid. Annals of the Academy of Medicine Singapore. 33(1). 100–102. 23 indexed citations
19.
Cheung, YB, Gordon Ng, Wen Hsin Koo, et al.. (2003). Measuring Quality of Life in Chinese Cancer Patients: A New Version of the Functional Living Index for Cancer (Chinese). Annals of the Academy of Medicine Singapore. 32(3). 376–380. 11 indexed citations
20.
Pang, J. A., Anwei Cheng, Hok Sum Chan, Dennis Poon, & G.L. French. (1989). The Bacteriology of Bronchiectasis in Hong Kong Investigated by Protected Catheter Brush and Bronchoalveolar Lavage. American Review of Respiratory Disease. 139(1). 14–17. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jianli Hu Breakdown of academic impact, for papers by Nan He Breakdown of academic impact, for papers by Qingyun Long Breakdown of academic impact, for papers by Jaewoong Lee Breakdown of academic impact, for papers by Susan Shamimi‐Noori Breakdown of academic impact, for papers by Tiecheng Liu Breakdown of academic impact, for papers by Daniel Glass Breakdown of academic impact, for papers by Shi Wang Breakdown of academic impact, for papers by Piaopiao Jin Breakdown of academic impact, for papers by Amy P. Wu
Rankless by CCL
2026